Joshua D. Rosenblat, MD

JCP
Correction

April 22, 2020

Joshua D. Rosenblat, Andre F. Carvalho, Madeline Li, et al
JCP
Letter to the Editor

January 28, 2020

 Rosenblat and McIntyre reply to the letter "Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?" by Swainson and Khullar.
Joshua D. Rosenblat, Roger S. McIntyre
JCP
Review Article

April 16, 2019

Intravenous ketamine has rapid and robust antidepressant effects. Read this systematic review to learn if oral ketamine also has efficacy and tolerability in depressed individuals.
Joshua D. Rosenblat, Andre F. Carvalho, Madeline Li, et al
PCC
Article

November 1, 2018

What patient-reported factors influence medication treatment decisions among individuals with bipolar and unipolar depression? The authors of this article conducted a survey to answer this question. Their findings may...
Joshua D. Rosenblat, Gregory E. Simon, Gary S. Sachs, et al
JCP
Review Article

June 28, 2017

In theory, pharmacogenomic testing in patients with depression can improve clinical outcomes by guiding antidepressant selection and dosing. This review looks at the current evidence to evaluate the clinical...
Joshua D. Rosenblat, Yena Lee, Roger S. McIntyre

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe